PharmaEssentia Corp.(TW:6446)
NT$1,335.00+55.00 (+4.30%)
TW:6446
PharmaEssentia Corp. financials statements
NT$1,335.00
At close:+55.00 (+4.30%)
PharmaEssentia Corp. (6446) Income Statement
PharmaEssentia Corp. Income Statement
Last quarter (Q2 2026), PharmaEssentia Corp.'s total revenue was NT$6.86B, an increase of 90.30% from the same quarter last year. In Q2, PharmaEssentia Corp.'s net income was NT$2.53B. See PharmaEssentia Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 15.63B | NT$ 9.73B | NT$ 5.11B | NT$ 2.88B | NT$ 656.51M | |
| NT$ 13.68B | NT$ 8.56B | NT$ 4.50B | NT$ 2.07B | NT$ 277.65M | |
| NT$ 8.75B | NT$ 6.82B | NT$ 6.41B | NT$ 4.10B | NT$ 3.10B | |
| Depreciation and Amortization | NT$ 398.60M | NT$ 367.71M | NT$ 268.76M | NT$ 227.92M | NT$ 227.08M |
| NT$ 5.41B | NT$ 3.38B | NT$ -671.49M | NT$ -1.60B | NT$ -2.57B | |
| NT$ 4.93B | NT$ 1.74B | NT$ -1.91B | NT$ -2.03B | NT$ -2.82B | |
| NT$ 54.71M | NT$ 1.26B | NT$ 926.46M | NT$ 186.32M | NT$ 11.42M | |
| NT$ 4.98B | NT$ 2.99B | NT$ -986.93M | NT$ -1.84B | NT$ -2.81B | |
| NT$ 5.05B | NT$ 2.97B | NT$ -623.84M | NT$ -1.37B | NT$ -2.81B | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 13.64 | NT$ 8.08 | NT$ -1.74 | NT$ -4.36 | NT$ -9.74 |
| Diluted EPS | NT$ 13.64 | NT$ 8.01 | NT$ -1.74 | NT$ -4.36 | NT$ -9.74 |
| Weighted Average Shares Outstanding | 369.88M | 361.15M | 357.63M | 315.19M | 288.52M |
| Weighted Average Shares Outstanding (Diluted) | 369.88M | 362.79M | 357.63M | 315.19M | 288.52M |
Currency in TWD

